Patel Priti
Insider CIK 1859997 · NLTX Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NLTX Neoleukin Therapeutics, In | S Sale | 2023-04-03 | 2023-04-04 | 3,769 | $0.69 | $2.6K | 37,313 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | M Exercise deriv | 2023-03-31 | 2023-04-04 | 10,000 | — | $0 | 0 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | M Exercise | 2023-03-31 | 2023-04-04 | 10,000 | — | $0 | 41,082 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2023-02-02 | 2023-02-03 | 14,380 | $0.60 | $8.6K | 31,082 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | M Exercise deriv | 2023-02-01 | 2023-02-03 | 35,000 | — | $0 | 35,000 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | M Exercise | 2023-02-01 | 2023-02-03 | 35,000 | — | $0 | 45,462 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | A Award deriv | 2022-08-02 | 2022-08-04 | 250,000 | — | $0 | 250,000 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | S Sale | 2022-05-02 | 2022-05-03 | 5,538 | $1.22 | $6.8K | 6,462 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | M Exercise deriv | 2022-04-30 | 2022-05-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | M Exercise | 2022-04-30 | 2022-05-03 | 10,000 | — | $0 | 12,000 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | A Award deriv | 2022-02-01 | 2022-02-02 | 70,000 | — | $0 | 70,000 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | A Award deriv | 2021-08-03 | 2021-08-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | A Award deriv | 2021-04-30 | 2021-05-04 | 475,000 | — | $0 | 475,000 | SEC↗ |
| NLTX Neoleukin Therapeutics, In | A Award deriv | 2021-04-30 | 2021-05-04 | 20,000 | — | $0 | 20,000 | SEC↗ |